KC-4660

Jurkat-ITGAE-ITGB7 Cell Line

×
57160
Home » Jurkat-ITGAE-ITGB7 Cell Line

Background of Jurkat-ITGAE-ITGB7 Cell Line

ITGAE encodes integrin subunit alpha E and is also known as CD103. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. This gene encodes an I-domain-containing alpha integrin that undergoes post-translational cleavage in the extracellular domain, yielding disulfide-linked heavy and light chains. In combination with the beta 7 integrin, this protein forms the E-cadherin binding integrin known as the human mucosal lymphocyte-1 antigen.

ITGB7 encodes integrin subunit beta 7. Members of this family are adhesion receptors that function in signaling from the extracellular matrix to the cell. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. The encoded protein forms dimers with an alpha4 chain or an alphaE chain and plays a role in leukocyte adhesion.

Specifications

Catalog NumberKC-4660
Cell Line NameJurkat-ITGAE-ITGB7 Cell Line
NCBI/UniProt Accession NumberNM_002208 NM_000889
Clone Number21#
Host Cell LineJurkat
DescriptionJurkat-ITGAE-ITGB7 is a stable engineered cell line expressing human ITGAE-ITGB7
QuantityOne vial of frozen cells (≥2×10⁶ cells/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640+20% FBS+10% DMSO
Propagation MediumRPMI1640+10%FBS+0.75μg/mL Puromycin
Selection MarkerPuromycin
MorphologyLymphoblast
SubcultureSplit at a ratio of 1:4–1:6 every 2–3 days
Incubation37 °C with 5% CO₂
StorageLiquid nitrogen immediately upon receiving
Doubling TimeEstimated 19–36 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

Jurkat-ITGAE-ITGB7 cell line was generated using a lentiviral vector expressing the human ITGAE-ITGB7 sequence.

Characterization

Figure 1: Characterization of ITGAE ITGB7 in the Jurkat stable clone using PCR sequencing.

Figure 2: Characterization of ITGB7 overexpression in the Jurkat ITGAE ITGB7 stable clone using FACS.

Figure 3: Characterization of ITGAE overexpression in the Jurkat ITGAE ITGB7 stable clone using FACS.

Cell Resuscitation

  1. Pre-warm complete culture medium (basal medium and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO₂ incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:4–1:6 every 2–3 days upon reaching 80%–90% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the pellet in chilled freezing medium, ensuring a minimum cell density of 3×10⁶ cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

  1. Hu X, Li YQ, Li QG et al. Corrigendum to 'ITGAE defines CD8+Tumor-Infiltrating lymphocytes predicting a better prognostic survival in colorectal cancer' [EBioMedicine 35 (2018) 178-188]. EBioMedicine. 2026 Mar;125:106176. PMID: 41690251. doi: 10.1016/j.ebiom.2026.106176.
  2. Guo J, Huang F, Lu P et al. Epigenetic Regulation of ITGB7 Promotes Coronary Heart Disease via Immune and Metabolic Pathways: A Multimodal Mendelian Randomization Study. Cardiovascular therapeutics. 2026;2026:4885476. PMID: 41509664. doi: 10.1155/cdr/4885476.
  3. Hu X, Li YQ, Li QG et al. ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer. EBioMedicine. 2018 Sep;35:178-188. PMID: 30100393. doi: 10.1016/j.ebiom.2018.08.003.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.